FightMND Grant Awards Further Work Into ALS, Other Motor Neuron Diseases
CripChat Australia #198: Beyond the NDIS: Services and Supports for People with Disabilities
CripChat Australia #197: Quality and Safeguard Reforms – Will They Protect People with Disabilities?
CripChat Australia | On Ableism: Part 1: Discrimination, Prejudice, Intolerance
CripChat Australia #181: Senate Inquiry on the NDIS Reform Bill: Bombshells and Revelations
Australian Disability Limited
Send Us your News and/or Sports Tip:
Pharnext’s PXT864 Shows Promising Neuroprotective Effects in ALS, Early Study Shows
Innovate UK Grant Supports Early Work on Cell Therapy for ALS
AC Immune Working to Move TDP-43 Antibody Into Clinical Testing for ALS
Aural Analytics To Power Speech-Based Endpoints For The Healey Center ALS Platform Trial at Mass Gen
AstroRx Slows ALS Progression at All Doses Tested, Trial Shows
Study Probes Gut Microbiome Alterations, Probiotics in ALS Patients
Phase 3 Update: Levosimendan Fails to Ease Breathing Problems in ALS Patients
Ultrasound Measures of Muscle May Help in Diagnosing, Evaluating ALS
New FUS Mutation Linked to Aggressive ALS in Teenage Girl
Tofersen Safe, Appears to Slow Disease Progression in SOD1 ALS Patients, Phase 1/2 Trial Shows
ALS scientific breakthrough: Diabetes drug metformin shows promise in mouse study for a common type
Slower Progression Seen in US Veterans Living Longer Than Disease Norm